Over the past 12‑18 months the Veterinary IV Pump industry trends have accelerated through a series of strategic moves and regulatory shifts. In March 2024, Baxter Veterinary entered a global distribution partnership with PetTech Solutions, expanding access to its next‑generation smart pumps across Europe and Asia. July 2024 saw Zoetis acquire MediFlow Instruments for $210 million, a deal that consolidates proprietary micro‑fluidic technology and broadens the combined product portfolio. Earlier this year, B. Braun VetCare launched the VET‑Pulse 2.0, featuring AI‑driven dosage algorithms and wireless telemetry, positioning it as the first pump certified under the EU’s updated Medical Device Regulation (MDR) 2023 amendment. The U.S. Food and Drug Administration also released new guidance in February 2024, streamlining the approval pathway for battery‑free, disposable IV modules, prompting several startups to secure Series B funding, including AquaVet, which raised $45 million to scale its plug‑and‑play system. Collectively, these developments signal a shift toward integrated, data‑centric solutions and heightened emphasis on compliance, reshaping both enterprise procurement and clinic‑level adoption.